101 related articles for article (PubMed ID: 19486027)
21. The safety of sublingual immunotherapy with one or multiple pollen allergens in children.
Agostinis F; Foglia C; Landi M; Cottini M; Lombardi C; Canonica GW; Passalacqua G
Allergy; 2008 Dec; 63(12):1637-9. PubMed ID: 19032238
[TBL] [Abstract][Full Text] [Related]
22. Side-effects of injective allergen immunotherapy administered to intermittent or persistent allergic rhinitis patients.
Rogala B; Markiewicz-Bendkowska IB; Brzoza Z; Glück J; Oleś E
Rhinology; 2007 Jun; 45(2):134-9. PubMed ID: 17708460
[TBL] [Abstract][Full Text] [Related]
23. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.
Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R
Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808
[TBL] [Abstract][Full Text] [Related]
24. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
Goldberg A; Confino-Cohen R
J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
[TBL] [Abstract][Full Text] [Related]
25. [Multicenter drug surveillance of sublingual immunotherapy in allergic patients].
Almagro E; Asensio O; Bartolomé JM; Bosque M; de la Hoz B; Dolz I; Elorza J; Ferreiro M; García JM; Losada E
Allergol Immunopathol (Madr); 1995; 23(4):153-9. PubMed ID: 8553989
[TBL] [Abstract][Full Text] [Related]
26. [WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases].
Malling HJ
Wien Med Wochenschr; 1999; 149(14-15):410-4. PubMed ID: 10584284
[TBL] [Abstract][Full Text] [Related]
27. Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey.
Kartal O; Gulec M; Caliskaner Z; Musabak U; Sener O
Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):280-6. PubMed ID: 25858053
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of patients with allergic polysensitization: the POLISMAIL study.
Ciprandi G; Alesina R; Ariano R; Aurnia P; Borrelli P; Cadario G; Capristo A; Carosso A; Casino G; Castiglioni G; Cesinaro Di Rocco P; Colangelolo C; Di Gioacchino M; Di Paola MG; Errico G; Fiorina A; Gambuzza F; Gangemi S; Gasparini A; Giugno R; Iemoli E; Isola S; Maniero G; Marengo F; Mazzali P; Minelli M; Mosca M; Pellegrino R; Piconi S; Pravettoni V; Quaglio L; Ricciardi L; Ridolo E; Sillano V; Valle C; Varin E; Verini M; Zambito M; Riario-Sforza GG; Incorvaia C; Puccinelli P; Scurati S; Frati F
Eur Ann Allergy Clin Immunol; 2008 Nov; 40(3):77-83. PubMed ID: 19334371
[TBL] [Abstract][Full Text] [Related]
29. Nonfatal systemic reactions to subcutaneous immunotherapy: a 10-year experience.
Ragusa FV; Passalacqua G; Gambardella R; Campanari S; Barbieri MM; Scordamaglia A; Canonica GW
J Investig Allergol Clin Immunol; 1997; 7(3):151-4. PubMed ID: 9252872
[TBL] [Abstract][Full Text] [Related]
30. Incorrect allergy injections: allergists' experiences and recommendations for prevention.
Aaronson DW; Gandhi TK
J Allergy Clin Immunol; 2004 Jun; 113(6):1117-21. PubMed ID: 15208593
[TBL] [Abstract][Full Text] [Related]
31. The pattern of indoor and outdoor respiratory allergens in asthmatic adult patients in a humid and desert newly developed country.
Sattar HA; Mobayed H; al-Mohammed AA; Ibrahim AS; Jufairi AA; Balamurugan P; Mary VP; Bener A
Eur Ann Allergy Clin Immunol; 2003 Oct; 35(8):300-5. PubMed ID: 14653049
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapy units: a follow-up study.
Machín IS; Robaina JCG ; Bonnet C; de Blas C; Fernández-Caldas E; Triviño MS; de la Morin FT
J Investig Allergol Clin Immunol; 2001; 11(3):167-71. PubMed ID: 11831448
[TBL] [Abstract][Full Text] [Related]
33. Systemic reactions due to allergen immunotherapy.
Karaayvaz M; Erel F; Caliskaner Z; Ozangüç N
J Investig Allergol Clin Immunol; 1999; 9(1):39-44. PubMed ID: 10212856
[TBL] [Abstract][Full Text] [Related]
34. Safety of ultrashort-term sit with pollen allergoids adjuvanted by monophosphoryl lipid A: a prospective Italian survey.
Crivellaro M; Senna GE; Pappacoda A; Vanzelli R; Spacal B; Marchi G; Recchia G; Makatsori M
Eur Ann Allergy Clin Immunol; 2011 Mar; 43(2):58-60. PubMed ID: 21608374
[TBL] [Abstract][Full Text] [Related]
35. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment.
Calderón MA; Vidal C; Rodríguez Del Río P; Just J; Pfaar O; Tabar AI; Sánchez-Machín I; Bubel P; Borja J; Eberle P; Reiber R; Bouvier M; Lepelliez A; Klimek L; Demoly P;
Allergy; 2017 Mar; 72(3):462-472. PubMed ID: 27718250
[TBL] [Abstract][Full Text] [Related]
36. Tolerance of immunotherapy with a standardized extract of Alternaria tenuis in patients with rhinitis and bronchial asthma.
Tabar AI; Lizaso MT; García BE; Echechipía S; Olaguibel JM; Rodríguez A
J Investig Allergol Clin Immunol; 2000; 10(6):327-33. PubMed ID: 11206932
[TBL] [Abstract][Full Text] [Related]
37. Characterisation of systemic reactions to subcutaneous immunotherapy with airborne allergens and classification according to WAO 2010.
Santos N; Pereira AM; Silva R; Torres da Costa J; Plácido JL
Allergol Immunopathol (Madr); 2015; 43(1):25-31. PubMed ID: 24661594
[TBL] [Abstract][Full Text] [Related]
38. The safety profile of subcutaneous allergen immunotherapy in children with asthma in Hangzhou, East China.
Liu JL; Ning WX; Li SX; Xu YC; Wu L; Wang YS; Xu XF; Jiang Y; Sheng YJ; Zhou YL; Wang JH; Tang LF; Chen ZM
Allergol Immunopathol (Madr); 2017; 45(6):541-548. PubMed ID: 28629672
[TBL] [Abstract][Full Text] [Related]
39. Allergy immunotherapy as an early intervention in patients with child-onset atopic asthma.
Nagaya H; Maren S; Nagaya N
Int Arch Allergy Immunol; 2006; 139(1):9-15. PubMed ID: 16272821
[TBL] [Abstract][Full Text] [Related]
40. Vaccination during concurrent subcutaneous immunotherapy: safety of simultaneous application.
Ullrich D; Ullrich K; Mussler S; Thum-Oltmer S
Eur Ann Allergy Clin Immunol; 2015 Jan; 47(1):10-4. PubMed ID: 25599553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]